EVIDENCE-INFORMED APPROACHES TO TELEGLAUCOMA IN CANADA APRIL 2021 This report, endorsed by the C.G.S., C.O.S. and A.C.U.P.O., provides a review of evidence-informed approaches to teleglaucoma (TG) care in...
CANADIAN GLAUCOMA SOCIETY RECOMMENDATIONS FOR PROVIDING EYE CARE TO GLAUCOMA PATIENTS DURING THE COVID-19 PANDEMIC Revised June 9, 2020 The COVID-19 Pandemic has led to widespread implementation of...
CANADIAN GLAUCOMA SOCIETY RECOMMENDATIONS FOR PROVIDING EYE CARE TO GLAUCOMA PATIENTS DURING THE COVID-19 PANDEMIC Revised April 16, 2020 The COVID-19 Pandemic has led to widespread implementation of...
A PRACTICAL GUIDE TO THE PREGNANT AND BREASTFEEDING PATIENT WITH GLAUCOMA. (March 2020) Avner Belkin, MD, Teresa Chen, MD, Aurora R. DeOliveria, MD, Sandra M. Johnson,...
October 5, 2019 Canadian Glaucoma Society Evidence-Based Recommendations For The Risk Of Acute Angle Closure Glaucoma With Routine Use Of Hyoscine-N-Butylbromide (Buscopan) For Gastroenterological Procedures Background Hyoscine-n-butylbromide (Buscopan) is...
Click here to read the CADTH recommendations Report on MIGS. Canadian Glaucoma Society (CGS) Response Letter To The Canadian Agency For Drugs And Technologies In Health (CADTH)...
Although the Canadian Glaucoma Society (CGS) was officially founded in 1989, the origins of the CGS can be traced back to the early 1970s. Fellows of...
Canadian Ophthalmological Society (COS) & Canadian Glaucoma Society (CGS) Micro-Invasive Or Minimally Invasive Glaucoma Surgery (MIGS) Position Statement December 2017 Current surgical treatments for glaucoma are...
CSS Legacy Logo The first logo for the CGS was conceived in 2003, many years after the founding of the Society, by our first President, Dr Raymond...
